Literature DB >> 19085980

Using AutoDock for ligand-receptor docking.

Garrett M Morris1, Ruth Huey, Arthur J Olson.   

Abstract

This unit describes how to set up and analyze ligand-protein docking calculations using AutoDock and the graphical user interface, AutoDockTools (ADT). The AutoDock scoring function is a subset of the AMBER force field that treats molecules using the United Atom model. The unit uses an X-ray crystal structure of Indinavir bound to HIV-1 protease taken from the Protein Data Bank (UNIT 1.9) and shows how to prepare the ligand and receptor for AutoGrid, which computes grid maps needed by AutoDock. Indinavir is prepared for AutoDock, adding the polar hydrogens, and partial charges, and defining the rotatable bonds that will be explored during the docking. The input files for AutoGrid and AutoDock are created, and then the grid map calculation run, followed by the docking calculation in AutoDock. Finally, this unit describes some of the ways the results can be analyzed using AutoDockTools. Copyright 2008 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085980     DOI: 10.1002/0471250953.bi0814s24

Source DB:  PubMed          Journal:  Curr Protoc Bioinformatics        ISSN: 1934-3396


  144 in total

1.  Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.

Authors:  Robert P Sellers; Leslie D Alexander; Victoria A Johnson; Chun-Chieh Lin; Jeremiah Savage; Ricardo Corral; Jason Moss; Tim S Slugocki; Erinprit K Singh; Melinda R Davis; Suchitra Ravula; Jamie E Spicer; Jenna L Oelrich; Andrea Thornquist; Chung-Mao Pan; Shelli R McAlpine
Journal:  Bioorg Med Chem       Date:  2010-07-22       Impact factor: 3.641

2.  The importance of valine 114 in ligand binding in beta(2)-adrenergic receptor.

Authors:  Makoto Arakawa; Naveena Yanamala; Jasbir Upadhyaya; Andrew Halayko; Judith Klein-Seetharaman; Prashen Chelikani
Journal:  Protein Sci       Date:  2010-01       Impact factor: 6.725

3.  SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.

Authors:  Su Yan; Matthew W Elmes; Simon Tong; Kongzhen Hu; Monaf Awwa; Gary Y H Teng; Yunrong Jing; Matthew Freitag; Qianwen Gan; Timothy Clement; Longfei Wei; Joseph M Sweeney; Olivia M Joseph; Joyce Che; Gregory S Carbonetti; Liqun Wang; Diane M Bogdan; Jerome Falcone; Norbert Smietalo; Yuchen Zhou; Brian Ralph; Hao-Chi Hsu; Huilin Li; Robert C Rizzo; Dale G Deutsch; Martin Kaczocha; Iwao Ojima
Journal:  Eur J Med Chem       Date:  2018-05-26       Impact factor: 6.514

4.  PoxA, yjeK, and elongation factor P coordinately modulate virulence and drug resistance in Salmonella enterica.

Authors:  William Wiley Navarre; S Betty Zou; Hervé Roy; Jinglin Lucy Xie; Alexei Savchenko; Alexander Singer; Elena Edvokimova; Lynne R Prost; Runjun Kumar; Michael Ibba; Ferric C Fang
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

5.  In silico study of carvone derivatives as potential neuraminidase inhibitors.

Authors:  Noorakmar Jusoh; Hasanuddin Zainal; Azzmer Azzar Abdul Hamid; Noraslinda M Bunnori; Khairul Bariyyah Abd Halim; Shafida Abd Hamid
Journal:  J Mol Model       Date:  2018-03-15       Impact factor: 1.810

6.  Exploring 3D structure of human gonadotropin hormone receptor at antagonist state using homology modeling, molecular dynamic simulation, and cross-docking studies.

Authors:  Amirhossein Sakhteman; Minasadat Khoddami; Manica Negahdaripour; Arash Mehdizadeh; Mohsen Tatar; Younes Ghasemi
Journal:  J Mol Model       Date:  2016-08-25       Impact factor: 1.810

7.  Insights into the binding of Phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor.

Authors:  Xevi Biarnés; Alessandro Marchiori; Alejandro Giorgetti; Carmela Lanzara; Paolo Gasparini; Paolo Carloni; Stephan Born; Anne Brockhoff; Maik Behrens; Wolfgang Meyerhof
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

8.  Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2016-03-14       Impact factor: 3.850

9.  Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha.

Authors:  Thomas W Sturgill; Michael N Hall
Journal:  ACS Chem Biol       Date:  2009-12-18       Impact factor: 5.100

10.  BioDrugScreen: a computational drug design resource for ranking molecules docked to the human proteome.

Authors:  Liwei Li; Khuchtumur Bum-Erdene; Peter H Baenziger; Joshua J Rosen; Jamison R Hemmert; Joy A Nellis; Marlon E Pierce; Samy O Meroueh
Journal:  Nucleic Acids Res       Date:  2009-11-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.